DSM Capital Partners LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

DSM Capital Partners LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 249 shares of the medical equipment provider’s stock, valued at approximately $84,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $1,313,238,000. WCM Investment Management LLC bought a new position in Intuitive Surgical during the 4th quarter valued at approximately $575,536,000. International Assets Investment Management LLC increased its position in Intuitive Surgical by 32,360.5% during the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider’s stock valued at $231,721,000 after buying an additional 684,749 shares in the last quarter. Alphinity Investment Management Pty Ltd increased its position in Intuitive Surgical by 113.2% during the 4th quarter. Alphinity Investment Management Pty Ltd now owns 1,276,158 shares of the medical equipment provider’s stock valued at $430,525,000 after buying an additional 677,455 shares in the last quarter. Finally, J.P. Morgan Private Wealth Advisors LLC bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth $178,667,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other news, SVP Mark Brosius sold 196 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at $736,800. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the transaction, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Mark Brosius sold 196 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at $736,800. The disclosure for this sale can be found here. Over the last three months, insiders have sold 148,290 shares of company stock worth $57,207,154. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Up 1.6 %

NASDAQ ISRG traded up $6.46 on Friday, hitting $404.85. 1,082,160 shares of the company traded hands, compared to its average volume of 1,036,880. The company has a market capitalization of $143.60 billion, a price-to-earnings ratio of 73.08, a P/E/G ratio of 5.23 and a beta of 1.39. The business’s 50 day moving average price is $386.45 and its 200-day moving average price is $362.65. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $408.43.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 earnings per share. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Robert W. Baird reduced their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday, April 19th. BTIG Research lifted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Stifel Nicolaus lifted their target price on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, April 8th. Finally, Citigroup lifted their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Five research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $396.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.